Myeloid Leukemia

Myeloid leukemia is a type of leukemia affecting myeloid tissue.

Types include:

Other articles related to "leukemia, myeloid, myeloid leukemia":

List Of Human Clusters Of Differentiation
... adhesion expressed in T-cell acute lymphoblastic leukemia and T-cell lymphoma ... or adhesion expressed in B-cell chronic lymphocytic leukemia and T-cell lymphoma ... CD8 a co-receptor for MHC Class I also found on a subset of myeloid dendritic cells ...
Mast Cell Leukemia
... Mast cell leukemia is an extremely aggressive subtype of acute myeloid leukemia that usually occurs de novo but can, rarely, evolve from transformation of chronic myeloid leukemia into the more aggressive acute ... In a small proportion of cases, acute mast cell leukemia may evolve from a more progressive form of systemic mastocytosis ... The diagnosis of acute mast cell leukemia by the WHO criteria includes the requirement for a prevalence of 20% neoplastic mast cells in marrow and 10 ...
Benzen - Health Effects
... and laboratory data link benzene to aplastic anemia, acute leukemia, and bone marrow abnormalities ... malignancies that benzene is associated with include acute myeloid leukemia (AML), aplastic anemia, myleodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL ... levels of benzene in the air causes leukemia, a potentially fatal cancer of the blood-forming organs, in susceptible individuals ...
ICD-10 Chapter II: Neoplasms - C00–D48 – Neoplasms - (C81–C96) Malignant Neoplasms, Stated or Presumed To Be Primary, of Lymphoid, Haematopoietic and Rel
... neoplasms (C90.0) Multiple myeloma (C90.1) Plasma cell leukemia (C90.2) Plasmacytoma, extramedullary (C91) Lymphoid leukemia (C91.0) Acute lymphoblastic leukemia (C91.1) Chronic ...
Tyrosine Kinase - Clinical Significance - Chronic Myeloid Leukemia
... tyrosine kinase that is associated with chronic myeloid leukemia ... inhibitor of tyrosine kinase could be a viable option for the treatment of BCR-ABL-caused chronic myeloid leukemia ... STI571’s efficacy was tested in 83 patients with chronic myeloid leukemia, who were administered the dose orally during the chronic phase of their ...